Continuing Education  » Evidence Based / Specialty Updates  » Long-acting Insulin Option in Treating Diabetic Dogs

Long-acting Insulin Option in Treating Diabetic Dogs

CE Event Information

  • Description:
    Synthetic insulin is a modified form of insulin. Two products are commonly used in humans. Insulin glargine and insulin detemir are long-acting insulin analogs. Glargine is familiar to veterinary practitioners, as it is an option for use in diabetic dogs and cats. Though we know that insulin detemir is more potent than other forms of insulin in dogs, its clinical use and effects have not been well-described.

    In this week's Evidence Based Update, the findings of a clinical trial studying the effects of insulin detemir in dogs with diabetes mellitus are discussed including:
    - Recommended dosing
    - Efficacy of glycemic control
    - Adverse events associated with its use
    - Recommendations and considerations for use in diabetic dogs

    Running time: 11 mins
    Read more or post questions / comments on this topic: http://vetvine.com/forums/topic/497/long-acting-insulin-option-in-treating-diabetic-dogs

    Member fee: $9.95; Free registration for new Members, Unlimited Plus members and Evidence Based Update subscribers (https://www.vetvine.com/article/181/evidence-based-update-subscriptions)
  • Sponsor: VetVine Specialty Consulting Service
  • Presenter(s): Elisabeth Zenger, DVM, PhD, DACVIM (SAIM)
  • Fee (Basic Membership): $9.95